Evidence map›Paper›PMID 27367032›Full record

ArticleOncotarget2016

Capsaicin triggers autophagic cell survival which drives epithelial mesenchymal transition and chemoresistance in bladder cancer cells in an Hedgehog-dependent manner.

Consuelo Amantini, Maria Beatrice Morelli, Massimo Nabissi, Claudio Cardinali, Matteo Santoni, Angela Gismondi, Giorgio Santoni

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Trial
  3. Review
  4. Review
  5. Capsaicin: beyond TRPV1.Frontiers in nutrition · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Targeting hedgehog-driven mechanisms of drug-resistant cancers.Frontiers in molecular biosciences · 2023
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma.International journal of molecular sciences · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Consuelo AmantiniSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Maria Beatrice MorelliSchool of Pharmacy, Experimental Medicine Section, University of Camerino, Camerino, Italy.
Massimo NabissiSchool of Pharmacy, Experimental Medicine Section, University of Camerino, Camerino, Italy.
Claudio CardinaliSchool of Pharmacy, Experimental Medicine Section, University of Camerino, Camerino, Italy.
Matteo SantoniDepartment of Medical Oncology, Polytechnic University of Marche, Ancona, Italy.
Angela GismondiDepartment of Molecular Medicine, Sapienza University, Rome, Italy.
Giorgio SantoniSchool of Pharmacy, Experimental Medicine Section, University of Camerino, Camerino, Italy.
Università di Camerino · ITSapienza University of Rome · ITMarche Polytechnic University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer (BC) is a common urologic tumor characterized by high risk of recurrence and mortality. Capsaicin (CPS), used as an intravesical drug for overactive bladder, was demonstrated to induce cell death in different cancer cells including BC cells.Here we found that treatment of high-grade BC cells with high dose of CPS triggers autophagy. Infact, the CPS treatment alters the redox homeostasis by inducing production of radicals, mitochondrial depolarization, alterations of ADP/ATP ratio and activation of AMPK pathway stimulating the autophagic process in BC cells. The inhibition of autophagy, by using the specific inhibitor bafilomycin A or Beclin 1 knock-down, enhanced the CPS-induced cell death, demonstrating that CPS-induced autophagy acts as a pro-survival process in BC cells. By using PCR arrays and FACS analysis, we found that the CPS-treated BC cells displayed typical mesenchymal features of the epithelial mesenchymal transition (EMT) as elongated shape and over-expression of vimentin, α5 and β1 integrin subunits, integrin-like kinase and the anti-apoptotic Bcl-2 proteins. Moreover, we demonstrated that CPS treatment stimulates upregulation of Dhh/Ptch2/Zeb2 members of the Hedgehog signaling pathway, increases CD24, VEGFA and TIMP1 and decreases CD44 and ALCAM mRNA expression levels. By PTCH2 knock-down we found that the Hedgehog signaling pathway is involved in the CPS-induced autophagy and EMT phenotype.Finally, we also showed that the CPS-resistant EMT-positive BC cells displayed an increased drug-resistance to the cytotoxic effects of mitomycin C, gemcitabine and doxorubicine drugs commonly used in BC therapy.

Indexed as

AutophagyDrug Resistance, NeoplasmEpithelial-Mesenchymal TransitionAdenosine DiphosphateAdenosine TriphosphateBeclin-1CapsaicinCell Line, TumorCell SurvivalDeoxycytidineDoxorubicinGemcitabineGene Expression Regulation, NeoplasticGene SilencingHedgehog ProteinsHomeostasisAdenosine DiphosphateAdenosine TriphosphateBeclin-1BECN1 protein, humanCapsaicinDeoxycytidineDHH protein, humanDoxorubicinGemcitabineHedgehog ProteinsIHH protein, humanMitomycinPatched-2 ReceptorPTCH2 protein, humanReactive Oxygen SpeciesSHH protein, humanautophagybladder cancercapsaicinEMTHedgehog pathway

Identifiers

PMID27367032
PMCPMC5226576
OpenAlexW2465315499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.